TrialMultiple sclerosis (Houndmills, Basingstoke, England)2024

Teriflunomide in pediatric patients with relapsing multiple sclerosis: Open-label extension of TERIKIDS.

Tanuja Chitnis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.